• Publications
  • Influence
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.
This paper is the second in a series of three publications relating to the European evidence-based consensus on the diagnosis and management of Crohn's disease and concerns the management of active
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management.
TLDR
It is most important to distinguish patients with severe ulcerative colitis necessitating hospital admission from those with mild or moderately active disease who can generally be managed as outpatients, and to confirm the presence of active colitis by sigmoidoscopy before starting treatment.
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis.
TLDR
The aim of the Consensus is to promote a European perspective on the management of Crohn's disease and its dilemmas to avoid duplication of effort in the future.
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.
TLDR
The aim of this Consensus was therefore critically to evaluate the optimal strategies for the management of post-operative recurrence in CD.
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.
TLDR
This research highlights the need to understand more fully the role of microbiota in the development of Crohn's and Colitis and the role that language plays in the management of these conditions.
Reduced Paneth cell alpha-defensins in ileal Crohn's disease.
TLDR
It is reported that patients with CD of the ileum have reduced antibacterial activity in their intestinal mucosal extracts, and changes in HD5 expression levels, comparable to those observed in CD, had a pronounced impact on the luminal microbiota.
European evidence-based Consensus on the management of ulcerative colitis: Current management.
TLDR
The simplest, best validated and most widely used index for identifying acute severe UC remains that of Truelove & Wi_tts 3: any patient who has a bloody stool frequency ≥ 6/day and a tachycardia and temperature > 37.8 °C, or anaemia has severe ulcerative colitis.
European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis
TLDR
This document sets out the current European consensus on the diagnosis and management of CD, reached by the European Crohn’s and Colitis Organisation (ECCO) at a meeting held in Prague on 24 September 2004.
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis.
TLDR
The aim of the Consensus is to promote a European perspective on the management of ulcerative colitis (UC) and its dilemmas and to avoid duplication of effort in the future.
NF-κB- and AP-1-Mediated Induction of Human Beta Defensin-2 in Intestinal Epithelial Cells by Escherichia coli Nissle 1917: a Novel Effect of a Probiotic Bacterium
TLDR
It is demonstrated that probiotic bacteria may stimulate the intestinal innate defense through the upregulation of inducible antimicrobial peptides such as hBD-2.
...
1
2
3
4
5
...